分期经皮冠状动脉介入治疗对左主干病变的影响：来自EXCEL试验的见解 - Suppr

Impact of Staging Percutaneous Coronary Intervention in Left Main Artery Disease: Insights From the EXCEL Trial.

作者信息

Collet Carlos, Modolo Rodrigo, Banning Adrian, Kandzari David E, Stables Rod, Dressler Ovidiu, Sabik Joseph F, Kappetein A Pieter, Stone Gregg W, Serruys Patrick W

出版信息

JACC Cardiovasc Interv. 2019 Feb 25;12(4):411-412. doi: 10.1016/j.jcin.2018.11.027.

DOI:10.1016/j.jcin.2018.11.027

PMID:30784649

Abstract

摘要

相似文献

Impact of Staging Percutaneous Coronary Intervention in Left Main Artery Disease: Insights From the EXCEL Trial.分期经皮冠状动脉介入治疗对左主干病变的影响：来自EXCEL试验的见解

JACC Cardiovasc Interv. 2019 Feb 25;12(4):411-412. doi: 10.1016/j.jcin.2018.11.027.

Percutaneous Coronary Intervention of Left Main Disease: Pre- and Post-EXCEL (Evaluation of XIENCE Everolimus Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) and NOBLE (Nordic-Baltic-British Left Main Revascularization Study) Era.左主干疾病的经皮冠状动脉介入治疗：EXCEL（评价依维莫司洗脱支架 XIENCE 与冠状动脉旁路移植术治疗左主干血运重建效果）和 NOBLE（北欧-波罗的海-英国左主干血运重建研究）时代之前和之后。

Circ Cardiovasc Interv. 2017 Jun;10(6). doi: 10.1161/CIRCINTERVENTIONS.117.004792.

New-Generation Drug-Eluting Stents for Left Main In-Stent Restenosis: The DELTA-2 Registry.用于左主干支架内再狭窄的新一代药物洗脱支架：DELTA-2注册研究

JACC Cardiovasc Interv. 2018 Dec 10;11(23):2438-2440. doi: 10.1016/j.jcin.2018.08.016.

Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: an updated meta-analysis of 4 randomized, controlled trials.对于无保护左主干冠状动脉疾病，冠状动脉旁路移植术优于第一代药物洗脱支架：4项随机对照试验的更新荟萃分析。

J Thorac Cardiovasc Surg. 2014 Nov;148(5):2430-2. doi: 10.1016/j.jtcvs.2014.08.028. Epub 2014 Aug 19.

Long-term prognostic value of risk scores after drug-eluting stent implantation for unprotected left main coronary artery: A pooled analysis of the ISAR-LEFT-MAIN and ISAR-LEFT-MAIN 2 randomized clinical trials.药物洗脱支架植入术后无保护左主干冠状动脉风险评分的长期预后价值：ISAR-LEFT-MAIN和ISAR-LEFT-MAIN 2随机临床试验的汇总分析

Catheter Cardiovasc Interv. 2017 Jan;89(1):1-10. doi: 10.1002/ccd.26645. Epub 2016 Aug 12.

Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) Studies.比较单纯血管造影方法与紫杉醇经皮冠状动脉介入治疗和心脏手术评分方法在左主干冠状动脉支架置入中的协同作用：系列 PRECOMBAT（使用依维莫司洗脱支架在左主干冠状动脉疾病患者中进行旁路手术与血管成形术的随机比较的首项研究）的汇总分析。

Circ Cardiovasc Interv. 2018 Jan;11(1):e005374. doi: 10.1161/CIRCINTERVENTIONS.117.005374.

Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.经皮冠状动脉介入治疗（PCI）联合药物洗脱支架（DES）治疗女性患者中冠状动脉钙化的相关性及其影响：来自女性创新和药物洗脱支架（WIN-DES）合作研究。

JACC Cardiovasc Interv. 2016 Sep 26;9(18):1890-901. doi: 10.1016/j.jcin.2016.06.022.

B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.B 型利钠肽评估在左主干冠状动脉疾病血运重建患者中的应用：来自 EXCEL 试验的分析。

Circulation. 2018 Jul 31;138(5):469-478. doi: 10.1161/CIRCULATIONAHA.118.033631.

Current Interventions for the Left Main Bifurcation.左主干分叉病变的现行介入治疗

JACC Cardiovasc Interv. 2017 May 8;10(9):849-865. doi: 10.1016/j.jcin.2017.02.037.

Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.冠状动脉旁路移植术与药物洗脱支架置入术治疗左主干或多支冠状动脉疾病：一项个体患者数据的荟萃分析。

JACC Cardiovasc Interv. 2016 Dec 26;9(24):2481-2489. doi: 10.1016/j.jcin.2016.10.008.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of Staging Percutaneous Coronary Intervention in Left Main Artery Disease: Insights From the EXCEL Trial.

作者信息

出版信息

相似文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献